Journal
TOXICS
Volume 9, Issue 9, Pages -Publisher
MDPI
DOI: 10.3390/toxics9090204
Keywords
biomonitoring; nanoparticles; lung diseases; mineralogical analysis of broncho-alveolar lavages; occupational exposure
Categories
Funding
- Fonds de Recherche en Sante Respiratoire de la Societe de Pneumologie de Langue Francaise (NanoPI grant)
- Canceropole CLARA (Expo-Nano grant)
- Sante-Environnement Rhone-Alpes (EnviteRA)
Ask authors/readers for more resources
The biomonitoring of nanoparticles in broncho-alveolar lavages of patients with lung diseases suggest a potential role of inhaled nanoparticles in respiratory physiopathology. Most patients had high probability of exposure to unintentionally released nanoparticles, with varying proportions depending on the respiratory disease. Further investigations are required to draw firm conclusions on the contribution of inhaled particles to idiopathic lung diseases.
The biomonitoring of nanoparticles in patients' broncho-alveolar lavages (BAL) could allow getting insights into the role of inhaled biopersistent nanoparticles in the etiology/development of some respiratory diseases. Our objective was to investigate the relationship between the biomonitoring of nanoparticles in BAL, interstitial lung diseases and occupational exposure to these particles released unintentionally. We analyzed data from a cohort of 100 patients suffering from lung diseases (NanoPI clinical trial, ClinicalTrials.gov Identifier: NCT02549248) and observed that most of the patients showed a high probability of exposure to airborne unintentionally released nanoparticles (>50%), suggesting a potential role of inhaled nanoparticles in lung physiopathology. Depending on the respiratory disease, the amount of patients likely exposed to unintentionally released nanoparticles was variable (e.g., from 88% for idiopathic pulmonary fibrosis to 54% for sarcoidosis). These findings are consistent with the previously performed mineralogical analyses of BAL samples that suggested (i) a role of titanium nanoparticles in idiopathic pulmonary fibrosis and (ii) a contribution of silica submicron particles to sarcoidosis. Further investigations are necessary to draw firm conclusions but these first results strengthen the array of presumptions on the contribution of some inhaled particles (from nano to submicron size) to some idiopathic lung diseases.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available